Homology Medicines Overview

  • Founded
  • 2015

Founded
  • Status
  • Public

  • Employees
  • 104

Employees
  • Stock Symbol
  • FIXX

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $2.89

  • (As of Monday Closing)

Homology Medicines General Information

Description

Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • One Patriots Park
  • Bedford, MA 01730
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Homology Medicines Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.89 $2.76 $1.30 - $8.90 $158M 57.4M 369K -$0.06

Homology Medicines Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 42,512 34,017 405,519 641,845
Revenue 5,468 33,971 2,702 1,666
EBITDA 5,414 (87,596) (122,298) (103,625)
Net Income (2,586) (95,764) (128,694) (103,916)
Total Assets 310,958 211,721 263,737 310,567
Total Debt 23,983 23,934 15,442 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Homology Medicines Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Homology Medicines‘s full profile, request access.

Request a free trial

Homology Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Homology Medicines‘s full profile, request access.

Request a free trial

Homology Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering
Biotechnology
Bedford, MA
104 As of 2021
00000
0000 0000-00-00
000000000 00000

000000

s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000000
San Francisco, CA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000

0000 0

unt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Homology Medicines Competitors (78)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Audentes Therapeutics Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
You’re viewing 5 of 78 competitors. Get the full list »

Homology Medicines Patents

Homology Medicines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220160728-A1 Gene therapy methods Pending 05-Nov-2020 0000000000
US-20220106611-A1 Vectorized antibodies and uses thereof Pending 09-Sep-2020 000000000
US-20210393804-A1 Adeno-associated virus compositions for restoring pah gene function and methods of use thereof Pending 27-May-2020 0000000000
US-20210361778-A1 Adeno-associated virus compositions for ids gene transfer and methods of use thereof Pending 06-Apr-2020 000000000
US-20210261983-A1 Methods of treating phenylketonuria Pending 13-Jan-2020 A61K48/005
To view Homology Medicines’s complete patent history, request access »

Homology Medicines Executive Team (16)

Name Title Board Seat Contact Info
Arthur Tzianabos Ph.D President, Chief Executive Officer & Board Member
Albert Seymour Ph.D Chief Scientific Officer
Bradford Smith Chief Financial and Business Officer
Deborah Kinch Chief Development Officer
Paul Alloway Secretary, Administration & Chief Legal Officer, Legal
You’re viewing 5 of 16 executive team members. Get the full list »

Homology Medicines Board Members (14)

Name Representing Role Since
Alise Reicin MD Self Board Member 000 0000
Arthur Tzianabos Ph.D Homology Medicines President, Chief Executive Officer & Board Member 000 0000
Cameron Wheeler Ph.D Self Board Member 000 0000
Jason Ruth Ph.D 5AM Ventures Board Observer 000 0000
Jeffrey Poulton Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Homology Medicines Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Homology Medicines Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Homology Medicines‘s full profile, request access.

Request a free trial

Homology Medicines Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 10-Mar-2022 00000 0000 0000 Drug Discovery 000000 00
To view Homology Medicines’s complete investments history, request access »